Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
177
-
Total 13F shares, excl. options
-
62.5M
-
Shares change
-
-112K
-
Total reported value, excl. options
-
$1.61B
-
Value change
-
-$1.85M
-
Put/Call ratio
-
1.84
-
Number of buys
-
97
-
Number of sells
-
-86
-
Price
-
$25.67
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2015
199 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q2 2015.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.5M shares
of 115M outstanding shares and own 54.26% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (6.36M shares), VANGUARD GROUP INC (4.53M shares), SYSTEMATIC FINANCIAL MANAGEMENT LP (3.27M shares), OAK RIDGE INVESTMENTS LLC (2.75M shares), Bank of New York Mellon Corp (2.26M shares), KALMAR INVESTMENTS INC /DE/ (1.88M shares), BlackRock Fund Advisors (1.86M shares), Champlain Investment Partners, LLC (1.83M shares), Van Berkom & Associates Inc. (1.81M shares), and Invesco Ltd. (1.68M shares).
This table shows the top 177 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.